Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imaging in thyroid cancer

R J Galloway1, R C Smallridge

  • 1Division of Medicine, Walter Reed Army Institute of Research, Washington, DC, USA.

Endocrinology and Metabolism Clinics of North America
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial.

The Journal of clinical endocrinology and metabolism·2013
Same author

Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up.

The Journal of clinical endocrinology and metabolism·2012
Same author

Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.

Clinical oncology (Royal College of Radiologists (Great Britain))·2010
Same author

Acute and chronic back pain.

Bulletin of the Academy of Medicine, Toronto·2010
Same author

The Changes in the Appearance of the Wall of a Muscular Artery Between Diastolic and Systolic Blood Pressures.

The American journal of pathology·2009
Same author

Hormonal and cardiovascular response to low-intensity exercise with atropine administration.

Military medicine·2009
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Diagnosing medullary thyroid carcinoma (MTC) lacks an ideal imaging method. Current approaches combine imaging like MRI or ultrasound with isotopic studies, with Indium-labeled pentreotide favored in the US.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Medullary thyroid carcinoma (MTC) diagnosis presents challenges due to the absence of a definitive imaging modality.
  • Serum calcitonin and Carcinoembryonic antigen (CEA) are crucial biochemical markers for MTC diagnosis.
  • Current diagnostic protocols often involve a multimodal approach combining various imaging and isotopic techniques.

Purpose of the Study:

  • To review the current landscape of diagnostic imaging for medullary thyroid carcinoma.
  • To evaluate the utility and limitations of available imaging agents and methods.
  • To identify preferred diagnostic strategies in the United States.

Main Methods:

  • Review of existing literature on MTC imaging.
  • Analysis of the efficacy of different imaging modalities including MRI, ultrasound, and isotopic methods.

Related Experiment Videos

  • Discussion of specific radiopharmaceuticals like Tc(V)DMSA and Indium-labeled pentreotide.

    • Main Results:

    • No single imaging method is considered ideal for MTC diagnosis.
    • Combination imaging, particularly MRI or ultrasound with isotopic studies, is frequently employed.
    • Technetium-V dimercaptosuccinic acid (Tc(V)DMSA) is effective but not widely accessible in the US.
    • Indium-labeled pentreotide is identified as a leading imaging agent in the United States for MTC.

    Conclusions:

    • The diagnosis of MTC relies on a combination of clinical suspicion, biochemical markers, and multimodal imaging.
    • Indium-labeled pentreotide represents the current imaging agent of choice in the US for suspected MTC.
    • Further advancements in imaging are needed to establish an ideal diagnostic method for MTC.